Erlotinib (Tarceva)

DRUG10 trials

Conditions

Carcinoma, HepatocellularCarcinoma, Non-Small-Cell LungChemopreventionCholangiocarcinomaHead and Neck CancerLiver CancerLung CancerMetastatic Colorectal Cancer

Phase 1

Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)

CompletedNCT00955149

Mayo ClinicChemoprevention, Cholangiocarcinoma, Primary Sclerosing Cholangitis +1

Start: 2009-08-31End: 2013-04-30Updated: 2014-01-10

Phase 2

Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy

CompletedNCT00148772

Endeavor HealthProstate Cancer

Start: 2005-08-31End: 2008-08-31Target: 29Updated: 2011-06-28

Study of RADPLAT and Tarceva in Locally Advanced Head and Neck Squamous Cell Carcinoma (SCCA)

CompletedNCT00304278

Southern Illinois UniversityHead and Neck Cancer

Start: 2006-03-31End: 2015-12-31Updated: 2017-07-27

A Phase 2 Study of Tarceva for Untreated, Good Prognosis Patients With Advanced Non-Small Cell Lung Cancer

CompletedNCT00585533

University of UtahLung Cancer

Start: 2004-06-30End: 2012-03-31Updated: 2013-07-30

A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer.

CompletedNCT00605722

Hoffmann-La RocheLiver Cancer

Start: 2008-03-31End: 2010-09-30Updated: 2014-07-14

Phase 3

Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)

CompletedNCT00153803

Dartmouth-Hitchcock Medical CenterCarcinoma, Non-Small-Cell Lung, Non-small Cell Lung Cancer, NSCLC

Start: 2005-05-31End: 2014-04-30Updated: 2019-09-06

Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC)

CompletedNCT00440414

Hellenic Oncology Research GroupNon Small Cell Lung Cancer

Start: 2006-04-30End: 2010-04-30Target: 320Updated: 2010-08-19

Chemotherapy and Avastin Followed by Maintenance Treatment With Avastin +/- Tarceva

CompletedNCT00598156

Lund University HospitalMetastatic Colorectal Cancer

Start: 2007-06-30End: 2012-08-31Updated: 2013-04-22

Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma

CompletedNCT00901901

BayerCarcinoma, Hepatocellular

Start: 2009-05-21End: 2018-05-23Updated: 2019-05-30

Unknown Phase

Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung Adenocarcinoma

NCT00903292

National Cheng-Kung University HospitalNon-Small Cell Lung Cancer

Start: 2009-03-31End: 2010-12-31Target: 52Updated: 2009-05-18

Related Papers

A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial.

2013-06-1952 citations

Design and rationale for the non-interventional Global Investigation of Therapeutic DEcisions in Hepatocellular Carcinoma and Of its Treatment with Sorafenib (GIDEON) study.

2010-07-0153 citations